{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:12Z","timestamp":1790985252211,"version":"4.1.0"},"reference-count":159,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian state-funded project for ICBFM SB RAS","award":["122022100238-7"],"award-info":[{"award-number":["122022100238-7"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatitis is an inflammatory liver disease primarily caused by hepatitis A (HAV), B (HBV), C (HCV), D (HDV), and E (HEV) viruses. The chronic forms of hepatitis resulting from HBV and HCV infections can progress to cirrhosis or hepatocellular carcinoma (HCC), while acute hepatitis can lead to acute liver failure, sometimes resulting in fatality. Viral hepatitis was responsible for over 1 million reported deaths annually. The treatment of hepatitis caused by viral infections currently involves the use of interferon-\u03b1 (IFN-\u03b1), nucleoside inhibitors, and reverse transcriptase inhibitors (for HBV). However, these methods do not always lead to a complete cure for viral infections, and chronic forms of the disease pose significant treatment challenges. These facts underscore the urgent need to explore novel drug developments for the treatment of viral hepatitis. The discovery of the CRISPR\/Cas9 system and the subsequent development of various modifications of this system have represented a groundbreaking advance in the quest for innovative strategies in the treatment of viral infections. This technology enables the targeted disruption of specific regions of the genome of infectious agents or the direct manipulation of cellular factors involved in viral replication by introducing a double-strand DNA break, which is targeted by guide RNA (spacer). This review provides a comprehensive summary of our current knowledge regarding the application of the CRISPR\/Cas system in the regulation of viral infections caused by HAV, HBV, and HCV. It also highlights new strategies for drug development aimed at addressing both acute and chronic forms of viral hepatitis.<\/jats:p>","DOI":"10.3390\/ijms25010334","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T04:40:44Z","timestamp":1703565644000},"page":"334","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["CRISPR\/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections"],"prefix":"10.3390","volume":"25","author":[{"given":"Ulyana I.","family":"Bartosh","sequence":"first","affiliation":[{"name":"The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton S.","family":"Dome","sequence":"additional","affiliation":[{"name":"The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya V.","family":"Zhukova","sequence":"additional","affiliation":[{"name":"The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9235-9970","authenticated-orcid":false,"given":"Polina E.","family":"Karitskaya","sequence":"additional","affiliation":[{"name":"The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-3192","authenticated-orcid":false,"given":"Grigory A.","family":"Stepanov","sequence":"additional","affiliation":[{"name":"The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"ref_1","unstructured":"(2021, February 20). Hepatitis A. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-a."},{"key":"ref_2","unstructured":"(2021, January 26). Hepatitis B. Available online: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_3","unstructured":"(2021, February 01). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_4","unstructured":"(2021, February 19). Hepatitis E. Available online: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-e."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpgasthep1274","article-title":"Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives","volume":"5","author":"Zeuzem","year":"2008","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and Future Therapies of Hepatitis B: From Discovery to Cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rivero-Juarez, A., Vallejo, N., Lopez-Lopez, P., D\u00edaz-Mareque, A.I., Frias, M., Vallejo, A., Caballero-G\u00f3mez, J., Rodr\u00edguez-Velasco, M., Molina, E., and Aguilera, A. (2020). Ribavirin as a First Treatment Approach for Hepatitis e Virus Infection in Transplant Recipient Patients. Microorganisms, 8.","DOI":"10.3390\/microorganisms8010051"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/iub.2296","article-title":"CRISPR\/Cas9 Gene Editing: A New Therapeutic Approach in the Treatment of Infection and Autoimmunity","volume":"72","author":"Mohammadzadeh","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA\u2013Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered Regularly Interspaced Short Palindrome Repeats (CRISPRs) Have Spacers of Extrachromosomal Origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"ref_13","unstructured":"(2023, December 12). CRISPR Elements in Yersinia Pestis Acquire New Repeats by Preferential Uptake of Bacteriophage DNA, and Provide Additional Tools for Evolutionary Studies|Microbiology Society. Available online: https:\/\/www.microbiologyresearch.org\/content\/journal\/micro\/10.1099\/mic.0.27437-0."},{"key":"ref_14","unstructured":"(2023, December 12). CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA|Science. Available online: https:\/\/www.science.org\/doi\/10.1126\/science.1165771."},{"key":"ref_15","unstructured":"(2023, December 12). Evolutionary Classification of CRISPR\u2013Cas Systems: A Burst of Class 2 and Derived Variants|Nature Reviews Microbiology. Available online: https:\/\/www.nature.com\/articles\/s41579-019-0299-x."},{"key":"ref_16","unstructured":"(2023, December 12). Cas9\u2013crRNA Ribonucleoprotein Complex Mediates Specific DNA Cleavage for Adaptive Immunity in Bacteria PNAS. Available online: https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.1208507109."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"ref_18","unstructured":"(2023, December 12). Systematic Prediction of Genes Functionally Linked to CRISPR-Cas Systems by Gene Neighborhood Analysis|PNAS. Available online: https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.1803440115."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short Motif Sequences Determine the Targets of the Prokaryotic CRISPR Defence System","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"(2023, December 12). Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease|Genetics | Oxford Academic. Available online: https:\/\/academic.oup.com\/genetics\/article\/194\/4\/1029\/5935344?login=true.","DOI":"10.1534\/genetics.113.152710"},{"key":"ref_21","unstructured":"(2023, December 12). Multiplex Genome Engineering Using CRISPR\/Cas Systems|Science. Available online: https:\/\/www.science.org\/doi\/10.1126\/science.1231143."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3748\/wjg.v13.i1.14","article-title":"Hepatitis B Virus Taxonomy and Hepatitis B Virus Genotypes","volume":"13","author":"Schaefer","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus-like particles in serum of patients with australia-antigen-associated hepatitis","volume":"295","author":"Dane","year":"1970","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B Virus Infection\u2014Natural History and Clinical Consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/jvi.14.2.384-391.1974","article-title":"DNA of a Human Hepatitis B Virus Candidate","volume":"14","author":"Robinson","year":"1974","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1073\/pnas.72.11.4597","article-title":"Genome of Hepatitis B Virus: Restriction Enzyme Cleavage and Structure of DNA Extracted from Dane Particles","volume":"72","author":"Summers","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of Hepatitis B Virus at the Level of Transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular Biology of Hepatitis B Virus Infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.06.014","article-title":"Chronic Hepatitis B: A Wave of New Therapies on the Horizon","volume":"121","author":"Block","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_30","unstructured":"Virology (2021, January 14). Getting Rid of a Persistent Troublemaker to Cure Hepatitis\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/24626921\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/gtc.12437","article-title":"Highly Multiplexed CRISPR-Cas9-Nuclease and Cas9-Nickase Vectors for Inactivation of Hepatitis B Virus","volume":"21","author":"Sakuma","year":"2016","journal-title":"Genes Cells"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting Hepatitis B Virus cccDNA by CRISPR\/Cas9 Nuclease Efficiently Inhibits Viral Replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 Cleavage of Viral DNA Efficiently Suppresses Hepatitis B Virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Li, H., Sheng, C., Wang, S., Yang, L., Liang, Y., Huang, Y., Liu, H., Li, P., Yang, C., and Yang, X. (2017). Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00091"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.omtn.2018.05.006","article-title":"One-Vector System for Multiplexed CRISPR\/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors","volume":"12","author":"Schiwon","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1038\/s41598-017-07642-6","article-title":"SsAAVs Containing Cassettes Encoding SaCas9 and Guides Targeting Hepatitis B Virus Inactivate Replication of the Virus in Cultured Cells","volume":"7","author":"Scott","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 Nickase-Mediated Disruption of Hepatitis B Virus Open Reading Frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)\/CRISPR-Associated Cas9 System to Disrupt the Hepatitis B Virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of Hepatitis B Virus by the CRISPR\/Cas9 System via Targeting the Conserved Regions of the Viral Genome","volume":"96","author":"Liu","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1002\/jcb.27050","article-title":"CRISPR\/Cas9-Mediated Knockout of HBsAg Inhibits Proliferation and Tumorigenicity of HBV-Positive Hepatocellular Carcinoma Cells","volume":"119","author":"Song","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.26041","article-title":"Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients with Low Hepatitis B Virus Loads","volume":"57","author":"Tseng","year":"2013","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1134\/S0026893319010072","article-title":"Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR\/Cas9","volume":"53","author":"Kostyusheva","year":"2019","journal-title":"Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41598-019-38526-6","article-title":"Suppressing the NHEJ Pathway by DNA-PKcs Inhibitor NU7026 Prevents Degradation of HBV cccDNA Cleaved by CRISPR\/Cas9","volume":"9","author":"Kostyushev","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.7150\/thno.18114","article-title":"The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR\/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41598-017-05905-w","article-title":"Suppression of HBV Replication by the Expression of Nickase-and Nuclease Dead-Cas9","volume":"7","author":"Kurihara","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.omtn.2023.02.001","article-title":"Depleting Hepatitis B Virus Relaxed Circular DNA Is Necessary for Resolution of Infection by CRISPR-Cas9","volume":"31","author":"Kostyushev","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Qiao, L., and Luo, G.G. (2019). Human Apolipoprotein e Promotes Hepatitis B Virus Infection and Production. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007874"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1099\/vir.0.044412-0","article-title":"DNA Viruses and the Cellular DNA-Damage Response","volume":"93","author":"Turnell","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cam4.1468","article-title":"RFX1 Participates in Doxorubicin-Induced Hepatitis B Virus Reactivation","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kostyusheva, A., Brezgin, S., Bayurova, E., Gordeychuk, I., Isaguliants, M., Goptar, I., Urusov, F., Nikiforova, A., Volchkova, E., and Kostyushev, D. (2019). ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage. Viruses, 11.","DOI":"10.3390\/v11110997"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/JVI.02721-06","article-title":"Formation of Hepatitis B Virus Covalently Closed Circular DNA: Removal of Genome-Linked Protein","volume":"81","author":"Gao","year":"2007","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: An Intermediate of Covalently Closed Circular DNA Formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kitamura, K., Que, L., Shimadu, M., Koura, M., Ishihara, Y., Wakae, K., Nakamura, T., Watashi, K., Wakita, T., and Muramatsu, M. (2018). Flap Endonuclease 1 Is Involved in cccDNA Formation in the Hepatitis B Virus. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007124"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Brezgin, S., Kostyusheva, A., Bayurova, E., Gordeychuk, I., Isaguliants, M., Goptar, I., Nikiforova, A., Smirnov, V., Volchkova, E., and Glebe, D. (2019). Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors in Vitro. Microorganisms, 7.","DOI":"10.3390\/microorganisms7110533"},{"key":"ref_58","first-page":"21","article-title":"Overexpression of DNA-Methyltransferases in Persistency of cccDNA Pool in Chronic Hepatitis B","volume":"89","author":"Kostyushev","year":"2017","journal-title":"Ter. Arkhiv"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4014\/jmb.1509.09051","article-title":"Structural and Functional Insight into Proliferating Cell Nuclear Antigen","volume":"26","author":"Park","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Stoimenov, I., and Lagerqvist, A. (2012). The PCNA Pseudogenes in the Human Genome. BMC Res. Notes, 5.","DOI":"10.1186\/1756-0500-5-87"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.7150\/thno.34273","article-title":"LncRNA PCNAP1 Modulates Hepatitis b Virus Replication and Enhances Tumor Growth of Liver Cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e28058","DOI":"10.1002\/jmv.28058","article-title":"The Interplay of Long Noncoding RNAs and Hepatitis B Virus","volume":"95","author":"Sarfaraz","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Qi, Y., Gao, Z., Xu, G., Peng, B., Liu, C., Yan, H., Yao, Q., Sun, G., Liu, Y., and Tang, D. (2016). DNA Polymerase \u03ba Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005893"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Tang, L., Sheraz, M., McGrane, M., Chang, J., and Guo, J.T. (2019). DNA Polymerase Alpha Is Essential for Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007742"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/liv.12710","article-title":"Reversibility of Hepatitis B Virus Cirrhosis after Therapy: Who and Why?","volume":"35","author":"Bedossa","year":"2015","journal-title":"Liver Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1053\/j.gastro.2004.09.045","article-title":"Prevention of Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"127","author":"Lok","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_68","first-page":"9757","article-title":"Increased Expression of G9A Contributes to Carcinogenesis and Indicates Poor Prognosis in Hepatocellular Carcinoma","volume":"15","author":"Qin","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fimmu.2017.00429","article-title":"The Lysine Methyltransferase G9a in Immune Cell Differentiation and Function","volume":"8","author":"Scheer","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2017.05.015","article-title":"Histone Methyltransferase G9a Promotes Liver Cancer Development by Epigenetic Silencing of Tumor Suppressor Gene RARRES3","volume":"67","author":"Wei","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3892\/ol.2017.6396","article-title":"Role of C-X-C Chemokine Ligand 12\/C-X-C Chemokine Receptor 4 in the Progression of Hepatocellular Carcinoma (Review)","volume":"14","author":"Jeng","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.3892\/or.2017.5601","article-title":"CRISPR\/Cas9-Mediated Genome Engineering of CXCR4 Decreases the Malignancy of Hepatocellular Carcinoma Cells In Vitro and In Vivo","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2018.04.017","article-title":"Knockout of NCOA5 Impairs Proliferation and Migration of Hepatocellular Carcinoma Cells by Suppressing Epithelial-to-Mesenchymal Transition","volume":"500","author":"He","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.28411","article-title":"Aspartate \u03b2-Hydroxylase Modulates Cellular Senescence through Glycogen Synthase Kinase 3\u03b2 in Hepatocellular Carcinoma","volume":"63","author":"Iwagami","year":"2016","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/cas.13014","article-title":"HBx Mutations Promote Hepatoma Cell Migration through the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"107","author":"Chen","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.7150\/jca.31599","article-title":"Oncogenic WNt3A: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma","volume":"10","author":"Zheng","year":"2019","journal-title":"J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-015-1126-4","article-title":"Comprehensive Analyses of Mutations and Hepatitis B Virus Integration in Hepatocellular Carcinoma with Clinicopathological Features","volume":"51","author":"Asahina","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/cncr.11266","article-title":"Expression and Prognostic Role of Tumor Suppressor Gene PTEN\/MMAC1\/TEP1 in Hepatocellular Carcinoma","volume":"97","author":"Hu","year":"2003","journal-title":"Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/s41598-017-03070-8","article-title":"CRISPR\/Cas9-Mediated P53 and Pten Dual Mutation Accelerates Hepatocarcinogenesis in Adult Hepatitis B Virus Transgenic Mice","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx Gene of Hepatitis B Virus Induces Liver Cancer in Transgenic Mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1349-7006.2006.00299.x","article-title":"Molecular Functions and Biological Roles of Hepatitis B Virus x Protein","volume":"97","author":"Tang","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cellsig.2011.04.001","article-title":"Cdc42 in Oncogenic Transformation, Invasion, and Tumorigenesis","volume":"23","author":"Stengel","year":"2011","journal-title":"Cell. Signal."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Xu, Y., Qi, Y., Luo, J., Yang, J., Xie, Q., Deng, C., Su, N., Wei, W., Shi, D., and Xu, F. (2017). Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030586"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2014.136","article-title":"MicroRNAs in Liver Cancer: A Model for Investigating Pathogenesis and Novel Therapeutic Approaches","volume":"22","author":"Callegari","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/cdd.2017.87","article-title":"Hepatitis B Virus X Protein Promotes CREB-Mediated Activation of miR-3188 and Notch Signaling in Hepatocellular Carcinoma","volume":"24","author":"Zhou","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A Novel Orally Available Small Molecule That Inhibits Hepatitis B Virus Expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/acs.jmedchem.8b01245","article-title":"Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action","volume":"61","author":"Han","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.celrep.2019.10.113","article-title":"A Genome-Wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen Production","volume":"29","author":"Hyrina","year":"2019","journal-title":"Cell Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/286533a0","article-title":"Presence of Integrated Hepatitis B Virus DNA Sequences in Cellular DNA of Human Hepatocellular Carcinoma","volume":"286","author":"Brechot","year":"1980","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular Carcinoma","volume":"365","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-Cell Exhaustion in Chronic Hepatitis B Infection: Current Knowledge and Clinical Significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: Gene Silencing through Base-Editing-Induced Nonsense Mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","article-title":"CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons","volume":"67","author":"Billon","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.omtm.2020.09.002","article-title":"CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity","volume":"19","author":"Preece","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bunse, T., Kosinska, A.D., Michler, T., and Protzer, U. (2022). PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B. Biomolecules, 12.","DOI":"10.3390\/biom12030470"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.imlet.2014.09.001","article-title":"PD-1 mRNA Expression Is Associated with Clinical and Viral Profile and PD1 3\u2032-Untranslated Region Polymorphism in Patients with Chronic HBV Infection","volume":"162","author":"Zhang","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2020.12.004","article-title":"Enhanced Antiviral Benefit of Combination Therapy with Anti-HBV and Anti-PD1 gRNA\/Cas9 Produces a Synergistic Antiviral Effect in HBV Infection","volume":"130","author":"Zhen","year":"2021","journal-title":"Mol. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/febs.14094","article-title":"Virus\u2013Host Interplay in Hepatitis B Virus Infection and Epigenetic Treatment Strategies","volume":"284","author":"Hensel","year":"2017","journal-title":"FEBS J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13072-015-0023-7","article-title":"Strategies for Precision Modulation of Gene Expression by Epigenome Editing: An Overview","volume":"8","author":"Laufer","year":"2015","journal-title":"Epigenet. Chromatin"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Belema, M., and Meanwell, N.A. (2014). Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect. J. Med. Chem., 5057\u20135071. Available online: https:\/\/pubs.acs.org\/doi\/10.1021\/jm500335h.","DOI":"10.1021\/jm500335h"},{"key":"ref_101","first-page":"331","article-title":"Sofosbuvir: A Novel Oral Agent for Chronic Hepatitis C","volume":"27","author":"Cholongitas","year":"2014","journal-title":"Ann. Gastroenterol."},{"key":"ref_102","unstructured":"(2023, October 27). Daclatasvir, Sofosbuvir with or without Ribavirin for 24 Weeks in Hepatitis C Genotype 3 Cirrhosis: A Real-Life Study. Available online: https:\/\/www.elsevier.es\/en-revista-annals-hepatology-16-pdf-S1665268119300456."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s007050050479","article-title":"Classification, Nomenclature, and Database Development for Hepatitis C Virus (HCV) and Related Viruses: Proposals for Standardization","volume":"143","author":"Robertson","year":"1998","journal-title":"Arch. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and Cell Biology of the Hepatitis C Virus Life Cycle\u2014An Update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3350\/cmh.2013.19.1.17","article-title":"Hepatitis C Virus: Virology and Life Cycle","volume":"19","author":"Kim","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/rmv.542","article-title":"Host Factors Involved in the Replication of Hepatitis C Virus","volume":"17","author":"Moriishi","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/med.21554","article-title":"Evolution of Efficacious Pangenotypic Hepatitis C Virus Therapies","volume":"39","author":"Ashraf","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jvh.13270","article-title":"Prevalence of HCV Resistance-associated Substitutions among Treatment-failure Patients Receiving Direct-acting Antiviral Agents","volume":"27","author":"Liu","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1073\/pnas.1105797108","article-title":"Contribution of a Mutational Bias in Hepatitis C Virus Replication to the Genetic Barrier in the Development of Drug Resistance","volume":"108","author":"Powdrill","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Ashraf, M.U., Salman, H.M., Khalid, M.F., Khan, M.H.F., Anwar, S., Afzal, S., Idrees, M., and Chaudhary, S.U. (2021). CRISPR-Cas13a Mediated Targeting of Hepatitis C Virus Internal-Ribosomal Entry Site (IRES) as an Effective Antiviral Strategy. Biomed. Pharmacother., 136.","DOI":"10.1016\/j.biopha.2021.111239"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.1422340112","article-title":"Cas9-Mediated Targeting of Viral RNA in Eukaryotic Cells","volume":"112","author":"Price","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","first-page":"10-1128","article-title":"TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Jiang, J., Wu, X., Tang, H., and Luo, G. (2013). Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067982"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/JVI.00280-17","article-title":"Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission","volume":"91","author":"Fan","year":"2017","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nature18631","article-title":"Genetic Dissection of Flaviviridae Host Factors through Genome-Scale CRISPR Screens","volume":"535","author":"Marceau","year":"2016","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.78.3.1448-1455.2004","article-title":"CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.01888-08","article-title":"Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection to Prevent Superinfection","volume":"83","author":"Liu","year":"2009","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human Occludin Is a Hepatitis C Virus Entry Factor Required for Infection of Mouse Cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1248\/bpb.b15-01023","article-title":"Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection","volume":"39","author":"Shirasago","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/JVI.01977-07","article-title":"The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus","volume":"82","author":"Meertens","year":"2008","journal-title":"J. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.27815","article-title":"Selection of a Hepatitis C Virus with Altered Entry Factor Requirements Reveals a Genetic Interaction between the E1 Glycoprotein and Claudins","volume":"62","author":"Hopcraft","year":"2015","journal-title":"Hepatology"},{"key":"ref_122","first-page":"001512","article-title":"Optimized Cell Systems for the Investigation of Hepatitis C Virus E1E2 Glycoproteins","volume":"102","author":"Kalemera","year":"2020","journal-title":"J. Gen. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature18625","article-title":"A CRISPR Screen Defines a Signal Peptide Processing Pathway Required by Flaviviruses","volume":"535","author":"Zhang","year":"2016","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbamcr.2011.11.007","article-title":"Broad Action of Hsp90 as a Host Chaperone Required for Viral Replication","volume":"1823","author":"Geller","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1038\/srep16699","article-title":"Involvement of FKBP6 in Hepatitis C Virus Replication","volume":"5","author":"Kasai","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2011.03.014","article-title":"No-Nonsense Functions for Long Noncoding RNAs","volume":"145","author":"Nagano","year":"2011","journal-title":"Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hep.30266","article-title":"A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha\u2013Inducible Protein 6","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/BTT.S433872","article-title":"Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value","volume":"17","author":"Essa","year":"2023","journal-title":"Biol. Targets Ther."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Bukong, T.N., Momen-Heravi, F., Kodys, K., Bala, S., and Szabo, G. (2014). Exosomes from Hepatitis C Infected Patients Transmit HCV Infection and Contain Replication Competent Viral RNA in Complex with Ago2-miR122-HSP90. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004424"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Li, J., Abosmaha, E., Coffin, C.S., Labont\u00e9, P., and Bukong, T.N. (2020). Reticulon-3 Modulates the Incorporation of Replication Competent Hepatitis C Virus Molecules for Release inside Infectious Exosomes. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239153"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.7150\/thno.50992","article-title":"Virus-Induced P38 MAPK Activation Facilitates Viral Infection","volume":"10","author":"Cheng","year":"2020","journal-title":"Theranostics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1096\/fj.201800641R","article-title":"Effect of P-body Component Mov10 on HCV Virus Production and Infectivity","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient Genome Modification by CRISPR-Cas9 Nickase with Minimal off-Target Effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1099\/jgv.0.000283","article-title":"Inhibition of Hepatitis C Virus RNA Replication by ISG15 Does Not Require Its Conjugation to Protein Substrates by the HERC5 E3 Ligase","volume":"96","author":"Domingues","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"38336","DOI":"10.1038\/srep38336","article-title":"STAT1 Is Essential for the Inhibition of Hepatitis C Virus Replication by Interferon-\u03bb but Not by Interferon-\u03b1","volume":"6","author":"Yamauchi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","article-title":"TP53 Mutations and Hepatocellular Carcinoma: Insights into the Etiology and Pathogenesis of Liver Cancer","volume":"26","author":"Hussain","year":"2007","journal-title":"Oncogene"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1128\/JVI.05843-11","article-title":"HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle","volume":"85","author":"Narbus","year":"2011","journal-title":"J. Virol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mBio.00121-17","article-title":"Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced P53 Responses by Activating Protein Kinase R","volume":"8","author":"Mitchell","year":"2017","journal-title":"mBio"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Joyce, M.A., Berry-Wynne, K.M., Dos Santos, T., Addison, W.R., McFarlane, N., Hobman, T., and Tyrrell, D.L. (2019). HCV and Flaviviruses Hijack Cellular Mechanisms for Nuclear STAT2 Degradation: Up-Regulation of PDLIM2 Suppresses the Innate Immune Response. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007949"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/JVI.02009-17","article-title":"MicroRNA 130a Regulates Both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway","volume":"92","author":"Duan","year":"2018","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/PL00000854","article-title":"HuR and mRNA Stability","volume":"58","author":"Brennan","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_142","unstructured":"Averhoff, F.M., Khudyakov, Y., and Nelson, N.P. (2018). Plotkin\u2019s Vaccines, Elsevier."},{"key":"ref_143","unstructured":"Lemon, S.M., and Robertson, B.H. (1994). Viral Hepatitis and Liver Disease, Springer Japan."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12029","article-title":"A Pathogenic Picornavirus Acquires an Envelope by Hijacking Cellular Membranes","volume":"496","author":"Feng","year":"2013","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"a031807","DOI":"10.1101\/cshperspect.a031807","article-title":"Hepatitis a Virus Capsid Structure","volume":"9","author":"Stuart","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"a033480","DOI":"10.1101\/cshperspect.a033480","article-title":"Hepatitis A Virus Genome Organization and Replication Strategy","volume":"8","author":"McKnight","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e02065-17","DOI":"10.1128\/JVI.02065-17","article-title":"HAVCR1 (CD365) and Its Mouse Ortholog Are Functional Hepatitis A Virus (HAV) Cellular Receptors That Mediate HAV Infection","volume":"92","author":"Costafreda","year":"2018","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41564-020-0740-y","article-title":"Exosome Mimicry by a HAVCR1\u2013NPC1 Pathway of Endosomal Fusion Mediates Hepatitis A Virus Infection","volume":"5","author":"Costafreda","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/JVI.76.9.4162-4171.2002","article-title":"Japanese Encephalitis Virus Infection Initiates Endoplasmic Reticulum Stress and an Unfolded Protein Response","volume":"76","author":"Su","year":"2002","journal-title":"J. Virol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","article-title":"Hepatitis C Virus, ER Stress, and Oxidative Stress","volume":"13","author":"Tardif","year":"2005","journal-title":"Trends Microbiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.cdd.4401833","article-title":"Viruses, Endoplasmic Reticulum Stress, and Interferon Responses","volume":"13","author":"He","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3892\/etm.2017.4407","article-title":"Glucose-Regulated Protein 78 Is an Antiviral against Hepatitis a Virus Replication","volume":"13","author":"Jiang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and Safety of a Recombinant Hepatitis e Vaccine in Healthy Adults: A Large-Scale, Randomised, Double-Blind Placebo-Controlled, Phase 3 Trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Doceul, V., Bagdassarian, E., Demange, A., and Pavio, N. (2016). Zoonotic Hepatitis E Virus: Classification, Animal Reservoirs and Transmission Routes. Viruses, 8.","DOI":"10.3390\/v8100270"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"a031724","DOI":"10.1101\/cshperspect.a031724","article-title":"Hepatitis E Virus Genome Structure and Replication Strategy","volume":"9","author":"Kenney","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_156","first-page":"655","article-title":"Long Non-Coding RNA BST2\/BISPR Is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin","volume":"5","author":"Barriocanal","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"18428","DOI":"10.1073\/pnas.1011485107","article-title":"Structural Insight into the Mechanisms of Enveloped Virus Tethering by Tetherin","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Paliwal, D., Joshi, P., and Panda, S.K. (2017). Hepatitis E Virus (HEV) Egress: Role of BST2 (Tetherin) and Interferon Induced Long Noncoding RNA (lncRNA) BISPR. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187334"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"(2023, December 14). ViralZone: A Knowledge Resource to Understand Virus Diversity|Nucleic Acids Research|\u2019Oxford Academic. Available online: https:\/\/academic.oup.com\/nar\/article\/39\/suppl_1\/D576\/2508477?login=true.","DOI":"10.1093\/nar\/gkq901"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/334\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:07Z","timestamp":1760132527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25010334"],"URL":"https:\/\/doi.org\/10.3390\/ijms25010334","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}